{
    "Trade/Device Name(s)": [
        "VITROS Immunodiagnostic Products Rubella IgG Reagent Pack",
        "VITROS Immunodiagnostic Products Rubella IgG Calibrators",
        "VITROS Rubella IgG Reagent Pack",
        "VITROS Rubella IgG Calibrators",
        "VITROS Rubella IgG Assay"
    ],
    "Submitter Information": "Ortho-Clinical Diagnostics, Inc.",
    "510(k) Number": "K063143",
    "Predicate Device Reference 510(k) Number(s)": [
        "K954045"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "LFX"
    ],
    "Summary Letter Date": "December 13, 2006",
    "Summary Letter Received Date": "December 14, 2006",
    "Submission Date": "October 13, 2006",
    "Regulation Number(s)": [
        "21 CFR 866.3510"
    ],
    "Regulation Name(s)": [
        "Rubella virus serological reagents"
    ],
    "Analyte Class(es)": [
        "immunology",
        "serology",
        "virology"
    ],
    "Analyte(s)": [
        "Rubella IgG antibody"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma (EDTA)",
        "Plasma (Heparin)",
        "Plasma (Sodium Citrate)"
    ],
    "Specimen Container(s)": [
        "Heparin tube",
        "EDTA tube",
        "Sodium citrate tube"
    ],
    "Instrument(s)/Platform(s)": [
        "VITROS Immunodiagnostic System"
    ],
    "Method(s)/Technology(ies)": [
        "Immunometric assay",
        "Luminescent enzyme immunoassay"
    ],
    "Methodologies": [
        "Solid phase immunoassay",
        "Immunometric technique"
    ],
    "Submission Type(s)": [
        "Assay",
        "Calibrator",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for VITROS Rubella IgG immunometric assay on the VITROS Immunodiagnostic System for quantitative detection of rubella IgG antibodies in serum and plasma",
    "Indications for Use Summary": "Intended for the quantitative determination of IgG antibodies to rubella virus in human serum and plasma (heparin, EDTA or sodium citrate) to aid in the determination of immunity to rubella virus infection",
    "fda_folder": "Microbiology"
}